FDA Brief

Warning letters Food

FDA warning letter to

Livestock Nutrition Center

High riskIssued Dec 15, 2022Posted Mar 7, 2023Division of Human and Animal Food Operations West III

Livestock Nutrition Center's deer feed contained monensin, a cattle drug, and deer died; FDA cites hazard analysis and reporting failures.

What happened

FDA inspected the firm's animal feed mill in Gonzales, Texas, from August 18 to August 23, 2022, after the firm filed a Reportable Food Registry report (a required report to FDA when a food may cause serious harm or death). A customer's fallow deer herd got sick and died after eating the firm's non-medicated deer feed, and testing found monensin, a medicated cattle feed ingredient the deer feed was not made with; FDA said the deer died of monensin toxicity. The firm recalled the deer feed on July 27, 2022, and FDA found the monensin came from a medicated ingredient unloaded into a tank set aside for non-medicated feed.

What FDA found

  1. The hazard analysis did not consider that a medicated ingredient could cross-contaminate non-medicated feed when received, which is how monensin got into the deer feed.

    21 CFR 507.33(a)
  2. The hazard analysis did not evaluate fumonisin and deoxynivalenol (vomitoxin) hazards for grains and grain by-products such as corn, distillers grains, and cotton seed.

    21 CFR 507.33(a)
  3. The firm did not file a Reportable Food Registry report within 24 hours of determining on July 22, 2022, that the deer feed was a reportable food; it filed on August 1, 2022.

    Section 417(d)(1) of the FD&C Act
  4. The report left out required details such as the extent and nature of the adulteration and what happened to the food, and it covered only the deer feed, not other affected lots.

    Section 417(e) of the FD&C Act
  5. The feed was adulterated because it was held under insanitary conditions, with a medicated ingredient unloaded into a tank meant for non-medicated feed.

    Section 402(a)(4) of the FD&C Act [21 U.S.C. ยง 342(a)(4)]; 21 CFR 507.1(a)(1)(ii)

What FDA wants

FDA asks the firm to respond in writing within 15 working days with the specific steps taken to correct each violation, how recurrence will be prevented, and copies of related documentation. If corrections cannot be finished in that time, the firm must say why and give a completion date.

Who should pay attention

  • feed mills that handle both medicated and non-medicated products
  • brands that buy animal feed from contract manufacturers
  • companies with Reportable Food Registry reporting duties

This is a summary. Read the original letter on fda.gov.

Livestock Nutrition Center's FDA history

  1. Livestock Nutrition Center

    Livestock Nutrition Center made non-medicated animal feed contaminated with monensin, killing animals; FDA found preventive control failures.

    High risk

Full company page

Similar letters to other companies

  1. Baxter International Inc.

    Baxter's Round Lake injectable drug plant violated CGMP (manufacturing quality rules), with cephalosporin cross-contamination and sterile processing failures.

    High risk
  2. Signature Formulations LLC

    FDA warns Signature Formulations about contaminated contract-manufactured drug products and cross-contamination at its Phoenix facility.

    High risk
  3. Shoolin Pharma Chem LLP

    Shoolin Pharma Chem, an Indian API maker, warned over filthy conditions, missing test data, and cleaning failures; all U.S. APIs recalled.

    High risk
  4. Dabur India Limited

    FDA cites Dabur India for falsified records, incomplete lab data, and inadequate cleaning and process validation for over-the-counter drugs.

    High risk